Skip to content
Dx

HCPCS Level II · Procedures and professional services (temporary)

G2083Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About G2083

G2083 is an HCPCS Level II code in the G series (procedures and professional services (temporary)), describing office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation.

It was added to HCPCS effective 01/01/2020.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Visit esketamine, > 56m
Date added
01/01/2020
Action effective
01/01/2020
BETOS
M1B

Related G20xx codes

Common questions about G2083

Is HCPCS G2083 still valid?

Yes. G2083 is active in the CMS October 2026 HCPCS file.

Does Medicare cover G2083?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.